Skip to main content
Top

memo - Magazine of European Medical Oncology

Issue 1/2022

Content (21 Articles)

Hepatocellular carcinoma—neoadjuvant systemic and local treatment concepts to improve resectability rates and oncological outcome

Iveta Urban, Florian Primavesi, Klaus Bogner, Claudia Bartsch, Marlene Trattner, Alexandra Schmid, Stefan Stättner

Gastric Cancer short review

Innovative strategies in metastatic gastric cancer: a short review

Hannah Christina Puhr, Aysegul Ilhan-Mutlu

NSCLC short review

Checkpoint inhibitor pneumonitis: Short review of literature and case report

Romana Elisabeth Wass, David Lang, Andreas Horner, Bernd Lamprecht

The outcome of COVID-19 in patients with hematological malignancy

Pınar Tığlıoğlu, Murat Albayrak, Mesut Tığlıoğlu, Hacer Berna Afacan Öztürk, Merih Reis Aras, Buğra Sağlam, Senem Maral

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine